Quick Takeaways
- REPL - Replimune Group, Inc. has 29 insiders with reported activity on this page.
- Net insider value flow over the last year: -$962,484.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 29 Insiders of Replimune Group, Inc.
- Symbol
- REPL on Nasdaq
- Location
- Woburn, MA
What Changed
- Buy value: ; sell value: $962,483.
- Net share flow: -116,186.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$962,484.
Buys
$0
Shares: 0
Insiders: 0
Sells
$962,484
Shares: 116,186
Insiders: 7
Net
-$962,484
Shares: -116,186
Insiders: -7
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 6,500 | $0 | $52,065 | -$52,065 |
| 3-6 | 0 | 25,625 | $0 | $257,607 | -$257,607 |
| 6-9 | 0 | 9,154 | $0 | $49,157 | -$49,157 |
| 9-12 | 0 | 74,907 | $0 | $603,655 | -$603,655 |
Replimune Group, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Director, 10%+ Owner | $125,641,900 | Mixed | 01 Apr 2026 | ||
| Omega Fund IV, L.P. | 10%+ Owner | $103,049,420 | Mixed | 14 Mar 2022 | ||
| Robert Coffin | Director | $11,787,512 | Filing P/S | 16 May 2024 | ||
| Philip Astley-Sparke | Director | $10,911,441 | -$260,169 | -2.3% | Mixed | 01 Apr 2026 |
| Sushil Patel | Chief Executive Officer, Director | $5,988,146 | -$313,646 | -5% | Mixed | 01 Apr 2026 |
| Colin Love | Chief Operating Officer | $5,029,422 | Filing P/S | 16 May 2024 | ||
| Pamela Esposito | Chief Business Officer | $2,876,721 | Mixed | 11 Sep 2023 | ||
| Konstantinos Xynos | Chief Medical Officer | $1,905,096 | -$130,050 | -6.4% | Mixed | 01 Apr 2026 |
| Emily Luisa Hill | Chief Financial Officer | $1,864,527 | -$69,564 | -3.6% | Mixed | 01 Apr 2026 |
| Tanya Lewis | Chief Dev. Op. Officer | $1,477,400 | Mixed | 13 Jun 2023 | ||
| Jean M. Franchi | Chief Financial Officer | $1,405,928 | Mixed | 16 May 2023 | ||
| Christopher Sarchi | Chief Commercial Officer | $1,214,219 | -$129,637 | -9.6% | Filing P/S | 02 Apr 2026 |
| Andrew Schwendenman | Chief Accounting Officer | $877,076 | -$26,460 | -2.9% | Mixed | 01 Apr 2026 |
| Kapil Dhingra | Director | $0 | -$32,958 | -100% | Mixed | 01 Apr 2026 |
| Michael Goller | Director | Mixed | 05 Mar 2025 | |||
| Hugo Alexander Slootweg | Director | Mixed | 01 Apr 2023 | |||
| Veleka Peeples-Dyer | Director | Mixed | 01 Apr 2026 | |||
| Hyam Levitsky | Director | Mixed | 01 Apr 2024 | |||
| Christy J. Oliger | Director | Mixed | 01 Apr 2026 | |||
| Jason P. Rhodes | Director | Mixed | 01 Apr 2022 | |||
| Paolo Pucci | Director | Mixed | 01 Apr 2026 | |||
| Baker Bros. Advisors (GP) LLC | Director, 10%+ Owner | Mixed | 01 Apr 2026 | |||
| 667, L.P. | Director, 10%+ Owner | Mixed | 01 Apr 2026 | |||
| Baker Brothers Life Sciences LP | Director, 10%+ Owner | Mixed | 01 Apr 2026 | |||
| Felix Baker | Director, 10%+ Owner | Mixed | 01 Apr 2026 | |||
| Julian C. Baker | Director, 10%+ Owner | Mixed | 01 Apr 2026 | |||
| Dieter Weinand | Director | Mixed | 01 Apr 2026 | |||
| Madhavan Balachandran | Director | Mixed | 01 Apr 2026 | |||
| Joseph P. Slattery | Director | Mixed | 01 Apr 2026 |
Top shareholders of Replimune Group, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
3/4/5
13D/G
13F
|
Director, 10%+ Owner · Company |
14%
from 13D/G
|
10,160,595
mixed-class rows
|
$125,641,900 | — | 01 Apr 2026 | |
| Omega Fund IV, L.P. |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
9,453,260
mixed-class rows
|
$103,049,420 | — | 14 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
13D/G
|
Company · T. Rowe Price Associates, Inc. |
11%
from 13D/G
|
8,262,296
|
$80,310,000 | — | 31 Dec 2025 | |
| RTW INVESTMENTS, LP |
13F
13D/G
|
Company |
8.2%
from 13D/G
|
7,140,352
|
$69,404,221 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.6%
|
6,069,633
|
$58,996,834 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
4.8%
from 13D/G
|
3,776,198
|
$36,704,645 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
3,693,107
|
$35,897,000 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
3.7%
|
2,981,580
|
$28,980,955 | — | 31 Dec 2025 | |
| FCPM III SERVICES B.V. |
13F
|
Company |
3.5%
|
2,808,368
|
$27,297,337 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3.2%
|
2,575,042
|
$25,029,408 | — | 31 Dec 2025 | |
| Forbion Capital Fund III Cooperatief U.A. |
13D/G
|
— |
3.5%
|
2,808,368
|
$22,579,279 | -$11,344,215 | 31 Dec 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
2.8%
|
2,229,527
|
$21,671,002 | — | 31 Dec 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
2.6%
|
2,120,000
|
$20,619,200 | — | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.3%
|
1,807,368
|
$17,567,617 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,750,194
|
$17,015,933 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13D/G
13F
|
Company |
4.7%
|
3,629,902
|
$15,209,289 | -$3,488,586 | 30 Sep 2025 | |
| Commodore Capital LP |
13F
|
Company |
1.8%
|
1,425,000
|
$13,851,000 | — | 31 Dec 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
1.8%
|
1,410,497
|
$13,710,031 | — | 31 Dec 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
1.5%
|
1,241,322
|
$12,065,650 | — | 31 Dec 2025 | |
| Robert Coffin |
3/4/5
|
Director |
—
class O/S missing
|
1,821,872
|
$11,787,512 | — | 16 May 2024 | |
| Philip Astley-Sparke |
3/4/5
|
Director |
—
mixed-class rows
|
1,505,071
mixed-class rows
|
$10,911,441 | -$260,169 | 01 Apr 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.4%
|
1,119,357
|
$10,880,742 | — | 31 Dec 2025 | |
| Redmile Group, LLC |
13F
13D/G
|
Company |
0.7%
from 13D/G
|
1,099,756
|
$10,689,628 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
925,173
|
$8,992,681 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1%
|
834,562
|
$8,111,943 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
814,888
|
$7,920,720 | — | 31 Dec 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
0.93%
|
750,000
|
$7,290,000 | — | 31 Dec 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.89%
|
714,226
|
$6,942,277 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.82%
|
658,096
|
$6,396,693 | — | 31 Dec 2025 | |
| Sushil Patel |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,161,676
mixed-class rows
|
$5,988,146 | -$313,646 | 01 Apr 2026 | |
| Invesco Ltd. |
13F
|
Company |
0.76%
|
613,015
|
$5,958,506 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.76%
|
606,844
|
$5,898,524 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.75%
|
604,313
|
$5,873,922 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
587,890
|
$5,714,291 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.73%
|
584,330
|
$5,679,688 | — | 31 Dec 2025 | |
| NAN FUNG TRINITY (HK) Ltd |
13F
|
Company |
0.72%
|
575,527
|
$5,594,122 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.71%
|
570,988
|
$5,550,003 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.67%
|
539,600
|
$5,244,912 | — | 31 Dec 2025 | |
| Colin Love |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
777,345
|
$5,029,422 | — | 16 May 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.57%
|
460,704
|
$4,478,043 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.55%
|
444,074
|
$4,316,399 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.5%
|
405,053
|
$3,937,115 | — | 31 Dec 2025 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.49%
|
392,915
|
$3,819,134 | — | 31 Dec 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.37%
|
296,843
|
$2,885,314 | — | 31 Dec 2025 | |
| Pamela Esposito |
3/4/5
|
Chief Business Officer |
—
mixed-class rows
|
349,469
mixed-class rows
|
$2,876,721 | — | 11 Sep 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.36%
|
292,185
|
$2,840,038 | — | 31 Dec 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.33%
|
266,484
|
$2,590,224 | — | 31 Dec 2025 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.31%
|
248,672
|
$2,417,092 | — | 31 Dec 2025 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
0.29%
|
230,997
|
$2,245,291 | — | 31 Dec 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.28%
|
228,570
|
$2,221,700 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Replimune Group, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Christopher Sarchi | REPL | Common Stock | Sale | -4.11% | $52,065 | $8.01 | -6,500 | 151,588 | 02 Apr 2026 | Direct |
| BAKER BROS. ADVISORS LP | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| BAKER BROS. ADVISORS LP | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Christopher Sarchi | REPL | Common Stock | Award | 33% | 50,000 | 201,588 | 01 Apr 2026 | Direct | ||
| Christopher Sarchi | REPL | Employee Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Philip Astley-Sparke | REPL | Common Stock | Award | 3.62% | 50,000 | 1,430,071 | 01 Apr 2026 | Direct | ||
| Philip Astley-Sparke | REPL | Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Christy J. Oliger | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Konstantinos Xynos | REPL | Common Stock | Award | 25% | 50,000 | 249,685 | 01 Apr 2026 | Direct | ||
| Konstantinos Xynos | REPL | Employee Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Madhavan Balachandran | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Andrew Schwendenman | REPL | Common Stock | Award | -24.2% | -36,667 | 114,951 | 01 Apr 2026 | Direct | ||
| Andrew Schwendenman | REPL | Employee Stock Option (right to buy) | Award | 55,000 | 55,000 | 01 Apr 2026 | Direct | |||
| Sushil Patel | REPL | Common Stock | Award | 47.1% | 251,240 | 784,816 | 01 Apr 2026 | Direct | ||
| Sushil Patel | REPL | Employee Stock Option (right to buy) | Award | 376,860 | 376,860 | 01 Apr 2026 | Direct | |||
| Kapil Dhingra | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Paolo Pucci | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Joseph P. Slattery | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Veleka Peeples-Dyer | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Emily Luisa Hill | REPL | Common Stock | Award | 25.7% | 50,000 | 244,368 | 01 Apr 2026 | Direct | ||
| Emily Luisa Hill | REPL | Employee Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Dieter Weinand | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Philip Astley-Sparke | REPL | Common Stock | Gift | -1.78% | -25,000 | 1,380,071 | 18 Feb 2026 | Direct | ||
| Sushil Patel | REPL | Common Stock | Award | 60% | 200,000 | 533,576 | 19 Dec 2025 | Direct | ||
| Konstantinos Xynos | REPL | Common Stock | Award | 43% | 60,000 | 199,685 | 19 Dec 2025 | Direct | ||
| Emily Luisa Hill | REPL | Common Stock | Award | 44.6% | 60,000 | 194,368 | 19 Dec 2025 | Direct | ||
| Christopher Sarchi | REPL | Common Stock | Award | 28.4% | 35,000 | 158,088 | 19 Dec 2025 | Direct | ||
| Andrew Schwendenman | REPL | Common Stock | Award | 14.6% | 10,000 | 78,284 | 19 Dec 2025 | Direct | ||
| Kapil Dhingra | REPL | Common Stock | Sale | -100% | $32,958 | $10.40 | -3,169 | 0 | 09 Dec 2025 | Direct |
| Kapil Dhingra | REPL | Common Stock | Options Exercise | 3,169 | 3,169 | 09 Dec 2025 | Direct | |||
| Kapil Dhingra | REPL | Stock Option (right to buy) | Options Exercise | -100% | -3,169 | 0 | 09 Dec 2025 | Direct | ||
| Sushil Patel | REPL | Common Stock | Sale | -2.91% | $111,300 | $11.13 | -10,000 | 333,576 | 02 Dec 2025 | Direct |
| Christopher Sarchi | REPL | Common Stock | Sale | -4.06% | $47,393 | $9.10 | -5,208 | 123,088 | 17 Nov 2025 | Direct |
| Konstantinos Xynos | REPL | Common Stock | Sale | -4.93% | $65,957 | $9.10 | -7,248 | 139,685 | 17 Nov 2025 | Direct |
| Emily Luisa Hill | REPL | Common Stock | Sale | -6.38% | $49,157 | $5.37 | -9,154 | 134,368 | 15 Aug 2025 | Direct |
| Philip Astley-Sparke | REPL | Common Stock | Sale | -2.25% | $260,169 | $8.06 | -32,279 | 1,405,071 | 20 May 2025 | Direct |
| Konstantinos Xynos | REPL | Common Stock | Sale | -5.13% | $64,093 | $8.06 | -7,952 | 146,933 | 20 May 2025 | Direct |
| Andrew Schwendenman | REPL | Common Stock | Sale | -4.59% | $26,460 | $8.05 | -3,287 | 68,284 | 20 May 2025 | Direct |
| Sushil Patel | REPL | Common Stock | Sale | -6.81% | $202,346 | $8.06 | -25,105 | 343,576 | 20 May 2025 | Direct |
| Emily Luisa Hill | REPL | Common Stock | Sale | -1.74% | $20,407 | $8.05 | -2,535 | 143,522 | 20 May 2025 | Direct |
| Christopher Sarchi | REPL | Common Stock | Sale | -2.84% | $30,179 | $8.05 | -3,749 | 128,296 | 20 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.